Human peripheral blood leukocyte engraftment into SCID mice: critical role of CD4(+) T cells.
We examined the influence of donor T lymphocytes on human peripheral blood leukocytes (PBL) engraftment into severe combined immune deficient (SCID) mice. Mice were injected with unfractionated or subset-depleted human PBL, and treated at various times with OKT3, a cytotoxic monoclonal antibody against human CD3(+) T lymphocytes. PBL engraftment, high levels of human Ig, and high incidence of lymphoproliferative disease (lpd) were found in mice transplanted with unfractionated PBL and CD8- or CD14-depleted PBL, and in mice treated with OKT3 at distance from PBL transfer. Animals xenografted with CD3- or CD4-depleted PBL, or treated at transplantation time with OKT3, had very low levels of human Ig and did not develop lpd. PBL engraftment was minimal or absent in these animals, as determined by immunohistochemistry, dot-blot, and RT-PCR analyses. These results demonstrate that the presence of donor CD4(+) T lymphocytes at transplantation time is necessary for observing human PBL engraftment into SCID mice, an essential condition for human Ig production and lpd development.
Duchosal
M A
MA
Division of Hematology, Department of Medicine, Centre Hospitalier Universitaire Vaudois, CH-1011 Lausanne, Switzerland. Michel.Duchosal@chuv.hospvd.ch
Mauray
S
S
Rüegg
M
M
Trouillet
P
P
Vallet
V
V
Aarden
L
L
Tissot
J D
JD
Schapira
M
M
D000818:Animals; D018951:Antigens, CD20 / Q000096:biosynthesis / Q000235:genetics; D001769:Blood / Q000276:immunology*; D017252:CD3 Complex / Q000096:biosynthesis / Q000235:genetics; D015496:CD4-Positive T-Lymphocytes / Q000276:immunology* / Q000637:transplantation; D002678:Chimera; D006801:Humans; D007074:Immunoglobulin G / Q000097:blood; D007075:Immunoglobulin M / Q000097:blood; D015850:Interleukin-6 / Q000096:biosynthesis; D017493:Leukocyte Common Antigens / Q000032:analysis; D007963:Leukocytes, Mononuclear / Q000637:transplantation*; D008212:Lymphocyte Depletion; D008232:Lymphoproliferative Disorders / Q000276:immunology* / Q000473:pathology; D051379:Mice; D016513:Mice, SCID; D016853:Muromonab-CD3 / Q000494:pharmacology; D012333:RNA, Messenger / Q000096:biosynthesis; D014183:Transplantation, Heterologous
D018951:Antigens, CD20; D017252:CD3 Complex; D007074:Immunoglobulin G; D007075:Immunoglobulin M; D015850:Interleukin-6; D016853:Muromonab-CD3; D012333:RNA, Messenger; D017493:Leukocyte Common Antigens